These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6394257)

  • 21. Clinical use of prostaglandins and prostaglandin synthetase inhibitors in cardiac problems of the newborn.
    Olley PM; Coceani F; Rowe RD; Swyer PR
    Adv Prostaglandin Thromboxane Res; 1980; 7():913-6. PubMed ID: 6768235
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of prostaglandin-E1 on patients with pulmonary atresia (author's transl)].
    Usui K; Kuroda N; Matsukawa S; Sato M; Fukuda M; Ishizawa E
    Kyobu Geka; 1978 Dec; 31(12):908-11. PubMed ID: 723053
    [No Abstract]   [Full Text] [Related]  

  • 23. Periosteal changes secondary to prostaglandin administration.
    Ringel RE; Haney PJ; Brenner JI; Mancuso TJ; Roberts GS; Moulton AL; Berman MA
    J Pediatr; 1983 Aug; 103(2):251-3. PubMed ID: 6683753
    [No Abstract]   [Full Text] [Related]  

  • 24. Prostaglandin treatment of newborns with ductal-dependent congenital heart disease.
    Linday LA; Engle MA
    Pediatr Ann; 1981 Apr; 10(4):29-38. PubMed ID: 7232040
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapeutic advances in neonatal cardiology].
    Salazar J; Burgueros M; Peŕez V
    An Esp Pediatr; 1983 Sep; 19 Suppl 18():37-45. PubMed ID: 6685984
    [No Abstract]   [Full Text] [Related]  

  • 26. Alprostadil (Prostin VR Pediatric Sterile Solution, The Upjohn Company).
    Roehl SL; Townsend RJ
    Drug Intell Clin Pharm; 1982 Nov; 16(11):823-32. PubMed ID: 6756848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prolonged prostaglandin E-1 therapy of newborn infants with congenital heart defects].
    Kertész E; Hencz P; Tekulics P; Beviz J; Száva J; Matkó I; Kovács G
    Orv Hetil; 1980 May; 121(20):1197-9. PubMed ID: 7413203
    [No Abstract]   [Full Text] [Related]  

  • 28. Ductal manipulation--a note of caution.
    Sharpe GL; Altshuler G
    J Pediatr; 1977 Feb; 90(2):335-7. PubMed ID: 830938
    [No Abstract]   [Full Text] [Related]  

  • 29. The inhibition of prostaglandin and prostacyclin synthesis in the clinical management of patent ductus arteriosus.
    Friedman WF; Kurlinski J; Jacob J; DiSessa TG; Gluck L; Merritt TA; Feldman BH
    Semin Perinatol; 1980 Apr; 4(2):125-33. PubMed ID: 6990503
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bone changes in infants induced by prostaglandin E1 as secondary hypertrophic osteoarthropathy].
    Tomiie F; Yamamoto A; Murakami K; Hamaoka K
    Nihon Igaku Hoshasen Gakkai Zasshi; 1982 Dec; 42(12):1127-36. PubMed ID: 6892060
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prostaglandins E1 in the treatment of neonatal cardiopathies related to ductus arteriosus. 19 cases].
    Maesen Y; Bosi G; Stijns M; Vliers A
    Arch Mal Coeur Vaiss; 1981 May; 74(5):579-85. PubMed ID: 6794479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter: Prostaglandin E1 for interrupted aortic arch in the neonate.
    Radford DJ; Bloom KR; Coceani F; Fariello R; Olley PM
    Lancet; 1976 Jul; 2(7976):95. PubMed ID: 59171
    [No Abstract]   [Full Text] [Related]  

  • 33. In partial defense of prolonged indomethacin therapy for patent ductus arteriosus.
    Hammerman C
    J Pediatr; 2000 May; 136(5):707-8. PubMed ID: 10802512
    [No Abstract]   [Full Text] [Related]  

  • 34. [The pharmacological manipulation of Botallo's duct in the duct-dependent congenital cardiopathies and in the preterm infants with respiratory distress. A review and personal findings].
    Distefano G
    Minerva Pediatr; 2005 Feb; 57(1):21-34. PubMed ID: 15791199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacological contraction of the ductus arteriosus (author's transl)].
    Momma K
    Kokyu To Junkan; 1981 Oct; 29(10):1026-34. PubMed ID: 7036305
    [No Abstract]   [Full Text] [Related]  

  • 36. Prostaglandin E1 in neonates with critical congenital heart disease.
    Dungan WT; Norton JB; Readinger RI; Sotomora RF
    J Ark Med Soc; 1982 Oct; 79(5):167-70. PubMed ID: 6183249
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prostaglandins in the newborn infant].
    Kääpä P
    Duodecim; 1984; 100(16):1072-7. PubMed ID: 6510262
    [No Abstract]   [Full Text] [Related]  

  • 38. Analysis of potential beneficial actions of prostaglandins in traumatic shock.
    Lefer AM; Araki H
    Prog Clin Biol Res; 1983; 111():199-210. PubMed ID: 6346328
    [No Abstract]   [Full Text] [Related]  

  • 39. Ductus arteriosus: developmental response to endogenous prostaglandins, oxygen, and indomethacin.
    Clyman RI
    Adv Prostaglandin Thromboxane Res; 1980; 7():887-90. PubMed ID: 6989208
    [No Abstract]   [Full Text] [Related]  

  • 40. [Analogs of prostaglandin-related substances and inhibitors of their formation and metabolism. Clinical application to the surgical field].
    Mishima Y
    Nihon Rinsho; 1985 Mar; 43(3):598-602. PubMed ID: 3892091
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.